Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05793658
Other study ID # 1/5/22
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 25, 2022
Est. completion date February 20, 2023

Study information

Verified date March 2023
Source Al Jedaani Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although appropriate sedation is recommended during colonoscopy, patients are at risk for adverse events e.g hypoventilation and hypoxemia due to inadvertent oversedation. The aim of this study was to evaluate the benefit of additional quantitative capnography monitoring ( respiratory rate )in management of patient undergoing colonoscopy under sedation in preventing or reducing the incidence of adverse events and also determine when to start the procedure and when to give and not to give increments of sedative drugs during the procedure.


Recruitment information / eligibility

Status Completed
Enrollment 74
Est. completion date February 20, 2023
Est. primary completion date February 20, 2023
Accepts healthy volunteers No
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - ASA 1 and 2 adult patients - Age from 20 to 50 years old - elective colonoscopy Exclusion Criteria: - American Society of Anesthesiologists (ASA) above Class II - History of psychiatric or neurological disease

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Standard capnography
Patients undergoing colonoscopy under sedation were randomly assigned to receive standard capnography monitoring or modified capnography monitoring which can be achieved by tucking capnography probe under the face mask.74 patients were enrolled. Patient characteristics were well balanced between the two groups 37 patients in each group.
Modified capnography
If Respiratory rate below 14 b/m: more sedation isn't not advised and the patient may develop airway obstruction and needs airway intervention ( like jaw thrust or oral airway) If respiratory rate more than 20 b/m it means this patient is prone to awake or to move and this patient in need for incremental dose of sedative drug ( e.g 20 to 30 mg propofol) Also roughly speaking respiratory rate from 16 to 18 b/m is the target

Locations

Country Name City State
Saudi Arabia Al Jedaani group of hospitals Jeddah Meccah

Sponsors (1)

Lead Sponsor Collaborator
Al Jedaani Hospital

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hypoxemia Detected by pulse oximeter 1 hours
Secondary Patient movements during the procedure Measured by questionnaire to the gastroenterologist (scale from 1 to 5) 1 hour
Secondary Effort exerted by the anesthesiologist ( the provider) Measured by questionnaire ( scale from 1 to 5 ) 1 hour
Secondary Patient satisfaction Measured by questionnaire ( scale from 1 to 5 ) 1 hour
Secondary Gastroenterologist satisfaction Measured by questionnaire ( scale from 1 to 5 ) 1 hour
See also
  Status Clinical Trial Phase
Completed NCT02001792 - Patient Positioning During Colonoscopy: Effects on Safety and Diagnostic Outcome N/A